81 Results

People

  1. Lacouture
    Lacouture
  2. Motzer
    Motzer
  3. Rogak
    Rogak
  4. Atkinson
    Atkinson
  5. Basch
    Basch
  6. Belum
    Belum
  7. Dusza
    Dusza
  8. Jackson
    Jackson
  9. Markova
    Markova
  10. Mauro
    Mauro

Groups

  1. Department of Medicine (48)
  2. Solid Tumor Oncology Division (28)
  3. Division of Subspecialty Medicine (19)
  4. Survivorship Research (18)
  5. Dermatology Service (13)
  6. Dermatology (13)
  7. Hematologic Malignancies, Division of (12)
  8. Center for Hematologic Malignancies (11)
  9. Epidemiology and Biostatistics (10)
  10. Genitourinary Oncology Service (10)
  1. "adverse events"
Formats
  1. Journal Article (60)
  2. Review (16)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (48)
  2. Solid Tumor Oncology Division (28)
  3. Division of Subspecialty Medicine (19)
  4. Survivorship Research (18)
  5. Dermatology (13)
  6. Dermatology Service (13)

More Groups

People
  1. Mario Lacouture (11)
  2. Lauren Rogak (5)
  3. Robert Motzer (5)
  4. Ethan Basch (4)
  5. Jedd Wolchok (4)
  6. Alina Markova (3)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (8)
  5. 2021 (3)
  6. 2020 (6)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (10)
  2. The Oncologist (4)
  3. Clinical Lymphoma, Myeloma and Leukemia (3)
  4. European Journal of Cancer (3)
  5. Anesthesia and Analgesia (2)
  6. Cancer (2)

More Publications

Publishers
  1. Elsevier Inc. (22)
  2. Oxford University Press (7)
  3. Lippincott Williams & Wilkins (6)
  4. Elsevier Science, Inc. (5)
  5. Demos Medical Publications (3)
  6. Sage Publications (3)

More Publishers

Results (81)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comparison of patient- and clinician-reported acute toxic effects during radiation therapy for primary breast cancer
    Journal Article

    Lapen, K.; King, C.; Braunstein, L. Z.; Khan, A. J.; Kamrava, M. R.; Gillespie, E. F.; Cook, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia
    Journal Article

    Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • An exploratory analysis of the “Was it worth it?” questionnaire as a novel metric to capture patient perceptions of cancer treatment
    Journal Article

    Thanarajasingam, G.; Basch, E.; Mead-Harvey, C.; Bennett, A. V.; Mazza, G. L.; Schwab, G.; Roydhouse, J.; Rogak, L. J.; Dueck, A. C.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Hyperglycaemic disorders associated with PCSK9 inhibitors: A real-world, pharmacovigilance study
    Journal Article

    Goldman, A.; Raschi, E.; Cukierman-Yaffe, T.; Dankner, R.; Shouval, R.; Shechter, M.; Ben-Zvi, I.; Gerstein, H. C.; Maor, E.
    European Journal of Preventive Cardiology (2022)

    Fulltext@MSK | Save
  • Endoscopic stenting for malignant biliary obstruction is technically successful in patients with preexisting duodenal stents
    Journal Article

    Simoes, P. K.; Schattner, M. A.; Gerdes, H.; Shah, P. M.; Kurtz, R. C.; Mendelsohn, R. B.
    Endoscopy International Open (2022)

    Fulltext@MSK | Save
  • Safety of MET tyrosine kinase inhibitors in patients with MET exon 14 skipping non-small cell lung cancer: A clinical review
    Review

    Cortot, A.; Le, X.; Smit, E.; Viteri, S.; Kato, T.; Sakai, H.; Park, K.; Camidge, D. R.; Berghoff, K.; Vlassak, S.; more...
    Clinical Lung Cancer (2022)

    Fulltext@MSK | Save
  • Infections due to dysregulated immunity: An emerging complication of cancer immunotherapy
    Review

    Morelli, T.; Fujita, K.; Redelman-Sidi, G.; Elkington, P. T.
    Thorax (2022)

    Fulltext@MSK | Save
  • Lifelong TKI therapy: How to manage cardiovascular and other risks
    Review

    Mauro, M. J.
    Hematology-American Society of Hematology Education Program (2021)

    Fulltext@MSK | Save
  • Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study
    Review

    Tabernero, J.; Velez, L.; Trevino, T. L.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Wasan, H.; Desai, J.; Ciardiello, F.; Yoshino, T.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save
  • Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials
    Journal Article

    Lopes, G. S.; Tournigand, C.; Olswold, C. L.; Cohen, R.; Kempf, E.; Saltz, L.; Goldberg, R. M.; Hurwitz, H.; Fuchs, C.; de Gramont, A.; more...
    Clinical Trials (2021)

    Fulltext@MSK | Save